Skip to main content
. 2019 Oct 10;9(10):220. doi: 10.3390/metabo9100220

Table 2.

Enzymological testing results and disease predictions. Enzymology values for individual PMD patient cell lines as grouped based on the system effected. Disease prediction was assigned using Z scores, as described in the Materials and Methods. Abbreviations: CI–IV, respiratory chain complexes I–IV; CS, citrate synthase; Str, structural.

Identifier # Gene System Rates of Enzymes Activity and Ratios to CS Z Scores Disease prediction
CS (nmol/min/mg) CI (⎢nmol/min/mg⎢) Rotenone sens (%) CII (⎢nmol/min/mg⎢) CIII (⎢/min/mg⎢) CIV (⎢/min/mg⎢) CI/CS CII/CS CIII/CS CIV/CS CS (nmol/min/mg) CI (⎢nmol/min/mg⎢) Rotenone sens (%) CII (⎢nmol/min/mg⎢) CIII (⎢/min/mg⎢) CIV (⎢/min/mg⎢) CI/CS CII/CS CIII/CS CIV/CS Sum (+ Z only)
45 TMEM126B Cl 143 27 42 69 29 2.6 0.19 0.48 0.20 0.018 1.7 5.2 8.4 1.9 −0.3 1.6 3.3 1.5 −1.3 0.5 24.2 Very likely
30 ACAD9 157 84 67 110 57 3.7 0.54 0.70 0.37 0.024 1.4 2.3 1.8 0.9 −3.8 0.8 0.3 −0.6 −4.7 −0.3 7.4 Possible
33 MT-ND1 139 25 39 86 28 4.5 0.18 0.62 0.20 0.032 1.7 5.3 9.1 1.5 −0.1 0.3 3.4 0.2 −1.1 −1.6 21.5 Very likely
48 ND6 221 176 80 108 26 5.1 0.80 0.49 0.12 0.023 0.1 −2.5 −1.6 0.9 0.1 −0.2 −1.9 1.5 0.6 −0.2 3.2 Unlikely
2737 NDUFS1 247 42 41 280 24 8.4 0.17 1.14 0.10 0.034 −0.5 4.4 8.6 −3.6 0.3 −2.5 3.5 -4.8 1.0 −1.9 17.7 Very likely
2736 NDUFS2 265 10 20 133 29 3.5 0.04 0.51 0.11 0.014 −0.8 6.1 14.2 0.2 −0.2 1.0 4.6 1.3 0.8 1.3 29.4 Very likely
2497 NDUFA13 AND PGM1 191 41 59 99 23 3.2 0.22 0.52 0.12 0.017 0.7 4.5 3.8 1.1 0.5 1.2 3.1 1.1 0.5 0.8 17.4 Very likely
52 SURF1 CIV 175 138 75 105 31 0.3 0.78 0.60 0.17 0.002 1.0 −0.5 −0.4 1.0 −0.5 3.3 −1.8 0.4 −0.6 3.1 8.8 Likely
55 SURF1 192 141 77 132 24 0.3 0.73 0.69 0.12 0.001 0.7 −0.7 −0.8 0.3 0.4 3.3 −1.4 −0.5 0.5 3.2 8.3 Likely
2264 MT-ATP6 CV 252 114 75 127 33 3.7 0.45 0.51 0.13 0.015 −0.6 0.7 −0.3 0.4 −0.8 0.9 1.1 1.3 0.3 1.1 5.7 Unlikely
47 AGK mtDNA 285 52 44 33 20 1.8 0.18 0.12 0.07 0.006 −1.2 3.9 7.9 2.8 0.9 2.2 3.4 5.1 1.6 2.4 30.1 Very likely
34 EARS2 200 98 75 107 29 2.4 0.49 0.53 0.15 0.012 0.5 1.6 −0.4 0.9 −0.3 1.8 0.7 1.0 0.0 1.5 8.0 Possible
43 MRPL44 186 88 68 101 25 1.6 0.47 0.54 0.13 0.009 0.8 2.1 1.5 1.1 0.3 2.4 0.9 0.9 0.2 2.0 12.1 Very likely
42 Large mtDNA deletion 177 121 74 120 24 7.1 0.68 0.68 0.14 0.040 1.0 0.4 −0.2 0.6 0.4 −1.6 −0.9 −0.4 0.2 −2.9 2.5 Unlikely
41 Large mtDNA deletion 280 162 79 161 37 8.1 0.58 0.57 0.13 0.029 −1.1 −1.8 −1.4 −0.5 −1.2 −2.3 0.0 0.6 0.3 −1.1 0.9 Unlikely
50 MT-TD 215 83 65 143 32 2.4 0.39 0.67 0.15 0.011 0.2 2.3 2.2 0.0 −0.6 1.8 1.6 −0.3 −0.1 1.6 9.7 Likely
36 MT-TE 241 136 72 172 40 4.8 0.56 0.71 0.16 0.020 −0.4 −0.4 0.4 −0.8 −1.6 0.1 0.1 −0.7 −0.4 0.3 0.8 Unlikely
57 MT-TE 249 107 71 85 25 2.7 0.43 0.34 0.10 0.011 −0.5 1.1 0.7 1.5 0.2 1.6 1.3 2.9 0.9 1.7 11.8 Very likely
58 MT-TL1 300 142 76 147 22 3.0 0.47 0.49 0.07 0.010 −1.5 −0.7 −0.5 −0.1 0.6 1.4 0.9 1.4 1.5 1.8 7.7 Possible
123 MT-TL1 160 74 61 136 15 7.8 0.46 0.85 0.10 0.049 1.3 2.8 3.3 0.2 1.4 −2.1 1.0 −2.1 1.0 −4.2 11.0 Likely
53 MT-TL1 115 76 65 143 25 3.0 0.66 1.24 0.22 0.026 2.2 2.7 2.2 0.0 0.2 1.4 −0.7 −5.8 −1.6 −0.7 8.7 Possible
54 MT-TL1 216 9 16 119 8 1.7 0.04 0.55 0.04 0.008 0.2 6.2 15.3 0.6 2.4 2.3 4.6 0.8 2.3 2.1 36.7 Very likely
72 MT-TL1 392 163 70 208 28 5.6 0.42 0.53 0.07 0.014 −3.4 −1.8 0.9 −1.7 −0.1 −0.5 1.4 1.0 1.5 1.2 6.0 Unlikely
40 MT-TL1 286 70 60 93 29 2.8 0.24 0.32 0.10 0.010 −1.3 3.0 3.6 1.3 −0.2 1.5 2.9 3.0 0.9 1.9 18.1 Very likely
51 MT-TN 179 90 70 100 20 1.9 0.50 0.56 0.11 0.010 0.9 2.0 1.0 1.1 0.9 2.2 0.6 0.8 0.7 1.8 12.0 Very likely
124 TWNK 214 94 73 94 24 1.3 0.44 0.44 0.11 0.006 0.2 1.7 0.1 1.3 0.4 2.6 1.2 2.0 0.7 2.4 12.5 Very likely
35 POLG 176 144 73 112 46 3.9 0.82 0.64 0.26 0.022 1.0 −0.8 0.2 0.8 −2.4 0.7 −2.1 0.0 −2.5 −0.1 2.7 Unlikely
38 POLG 191 123 84 110 19 4.6 0.64 0.58 0.10 0.024 0.7 0.2 −2.6 0.8 1.0 0.2 −0.6 0.6 0.9 −0.4 4.5 Unlikely
120 POLG 120 83 67 97 20 5.0 0.69 0.80 0.17 0.041 2.1 2.3 1.8 1.2 0.8 -0.1 −1.0 −1.6 −0.5 −3.1 8.3 Possible
59 ATAD3 Str 156 101 67 109 26 3.6 0.66 0.71 0.18 0.023 1.4 1.4 1.7 0.9 0.1 0.9 −0.7 −0.7 −0.8 −0.3 6.5 Unlikely
2130 PDHA1 TCA cycle 205 118 70 147 30 3.4 0.58 0.73 0.15 0.019 0.4 0.5 1.1 -0.1 -0.4 1.1 0.0 −0.9 0.0 0.5 3.6 Unlikely
31 PDHA1 147 85 71 111 26 2.3 0.58 0.75 0.18 0.016 1.6 2.2 0.7 0.8 0.2 1.8 0.0 −1.1 −0.6 0.9 8.2 Possible
128 SLC25A42 369 225 76 219 18 5.0 0.61 0.59 0.05 0.013 −3.0 −5.0 −0.7 −2.0 1.1 −0.1 −0.3 0.4 2.0 1.3 4.8 Possible
2738 SLC25A42 128 132 76 149 19 4.9 1.03 1.16 0.15 0.038 2.0 −0.2 −0.7 −0.2 1.0 0.0 −3.9 −5.1 0.0 −2.6 3.0 Unlikely
Median (+Z only) Controls 224 128 74 143 27 4.9 0.58 0.64 0.14 0.022 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.6 0.3 4.1 100% unlikely
Min 129 100 67 86 15 3.1 0.42 0.52 0.06 0.014 −1.9 −1.7 −1.7 −1.4 −2.0 −2.0 −2.3 −2.2 −1.0 −1.9 0.3
Max 318 160 80 195 43 7.6 0.84 0.87 0.19 0.034 1.9 1.4 1.7 1.5 1.5 1.3 1.4 1.2 1.8 1.2 6.1
1/4 percentile 184 109 72 113 21 3.6 0.51 0.59 0.08 0.018 −0.6 −0.7 −0.9 −1.0 −0.5 −0.7 −0.8 −1.0 −0.5 −0.9 2.3
3/4 percentile 253 142 77 182 31 5.9 0.67 0.74 0.17 0.027 0.8 1.0 0.6 0.8 0.8 0.9 0.6 0.5 1.3 0.6 5.6
n 12 12 12 11 12 12 12 11 12 12 12 12 12 11 12 12 12 11 12 12 12
% Coefficient of variation 22 15 5 27 30 28 20 16 33 30
Shapiro-Wilk test (p=) 0.98 0.95 0.98 0.89 0.96 0.94 0.96 0.95 0.91 0.95
Kolmogorov-Smirnov test (p=) >0.1 >0.1 >0.1 >0.1 >0.1 >0.1 >0.1 >0.1 >0.1 >0.1